Balchem Corporation (BCPC) Balance Sheet

A balance sheet shows what a company owns and owes, and shareholders' equity, at a single point in time.

Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide.

Total Assets Chart for Balchem Corporation

Balchem Corporation (BCPC) total assets for FY2025 were USD 1.7B, a 8.4% change from FY2024. Balchem Corporation's total assets grew from USD 3.6M in 1985 to USD 1.7B in 2025 (47332.2% over 40 years). Total assets compound annual growth rate: 5-year CAGR of 7.9%, 10-year CAGR of 6.8%, 20-year CAGR of 16.9%.

The most recent 3 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.

Total Assets (US Dollars)

R&D as % of Revenue

Compare with

Key Stats

Market Cap
$5.64B
Implied Share Price
$177.00
Enterprise Value
$5.39B
Revenue (TTM)
$1.09B
EBITDA
$269.41M
Profit Margin
15.14%
Trailing P/E
34.84
Forward P/E
29.33
Price/Book (MRQ)
4.12
Price/Sales (TTM)
5.20
EV/EBITDA
20.34
EV/Revenue
5.04
Dividend Yield
0.55%
Book Value
$40.76
Free Cash Flow (FY2025)
$173.07M
Free Cash Flow Yield
3.07%

Snapshot as of 24th October 2026 — not point-in-time controlled, may lag the live market by a few days.